NMN Supplement: Benefits, Dosage, NMN Vs NAD, Safety And FDA Status
An NMN supplement provides nicotinamide mononucleotide, a building block your cells use to make NAD+, a coenzyme involved in energy metabolism. In human trials, 250 to 900 mg of NMN a day consistently raised blood NAD+ levels and was well tolerated, but improvements in things people actually feel or measure, such as strength, metabolism or memory, have been small, inconsistent or absent. Brain and cognition claims rest almost entirely on animal research.
Disclosure: nootropic.org/ may earn a commission from qualifying purchases made through links on this page, including as an Amazon Associate. This never affects which products we recommend. Learn more.
Key Takeaways
- NMN raised blood NAD+ in every major human trial we reviewed, at doses from 250 to 900 mg a day.[2],[3],[5]
- A 2026 meta-analysis of 15 randomized trials found no clear increase in adverse events, but also no broad metabolic benefits.[6]
- A 2025 meta-analysis concluded that NMN and NR do not preserve muscle mass or function in adults over 60.[7]
- There are no published human trials showing NMN improves memory or focus; a 12-week trial of the related precursor NR raised NAD+ but did not improve cognition in people with mild cognitive impairment.[9]
- In September 2025, the FDA reversed its 2022 position and concluded NMN is not excluded from the definition of a dietary supplement.[12]
What Is NMN And How Does It Work?
Nicotinamide mononucleotide (NMN) is a molecule made from nicotinamide (a form of vitamin B3), a sugar and a phosphate group. Inside cells, NMN is converted directly into nicotinamide adenine dinucleotide (NAD+), a coenzyme that many enzymes depend on for energy production and cell maintenance. In mammals, the availability of NMN is a rate-limiting step in making NAD+.[1]
The interest in an NMN supplement comes from a simple chain of reasoning. NAD+ levels decline with age, and that decline has been linked in research to reduced mitochondrial energy production, oxidative stress, DNA damage, inflammation and cognitive impairment.[10] In rodents, restoring NAD+ with NMN improved a range of age-related problems.[10] The open question is whether raising NAD+ in healthy people produces benefits you can measure, and so far the answer is “not much yet.”
NMN Vs NAD: What Is The Difference?
NAD+ is the active coenzyme your cells use. NMN is one step upstream: a precursor your body converts into NAD+. That is the core difference between NMN and NAD. Supplements sold as “NAD” or “NAD+” exist, along with NAD+ IV drips, but nearly all of the controlled human research on oral products uses precursors such as NMN or nicotinamide riboside (NR) rather than NAD+ itself. If you are choosing between an NMN supplement and an oral NAD+ product, NMN has far more published human trial data behind it.
NMN Vs NR (Nicotinamide Riboside)
NR is a close cousin of NMN and sits one step further upstream. Both raise NAD+ in people. In a crossover trial, NR was well tolerated and increased NAD+ metabolism in healthy middle-aged and older adults,[8] and a 2026 trial found NR doubled blood NAD+ in people with mild cognitive impairment.[9] We are not aware of a large head-to-head human trial showing that one precursor produces better real-world outcomes than the other. A 2025 meta-analysis pooled both and found neither preserved muscle function in older adults.[7] Practically, the choice between “NMN NR supplement” products comes down to price, testing and personal preference rather than proven superiority.
| Compound | What It Is | Human Evidence |
|---|---|---|
| NAD+ | The active coenzyme | Little controlled oral supplement research |
| NMN | Direct precursor to NAD+ | Several RCTs; raises blood NAD+, functional results mixed |
| NR | Precursor that becomes NMN, then NAD+ | Several RCTs; raises blood NAD+, functional results mixed |
Nootropics Depot NMN Capsules
Single-ingredient nicotinamide mononucleotide at 250 mg per capsule, the dose used in several human trials, from a supplier that says it third-party lab tests for purity and identity. Buy only from Amazon listings “Sold by Nootropics Depot.”
NMN Benefits: What The Human Research Shows
Most NMN trials are small, short and conducted in specific groups (older Japanese men, overweight women with prediabetes, healthy middle-aged adults). Here is how the evidence stacks up.
| Outcome | Evidence Strength | Bottom Line |
|---|---|---|
| Raising blood NAD+ | Strong | Consistent across trials and doses |
| Insulin sensitivity | Limited | One positive 10-week trial; not confirmed in pooled data |
| Walking endurance | Preliminary | One trial positive; muscle meta-analysis negative |
| Muscle strength and mass in older adults | Not supported | No benefit in a 2025 meta-analysis |
| Memory, focus and cognition | Preliminary (animal only) | No human cognition trials of NMN |
Raising NAD+ Levels (Evidence: Strong)
This is the one thing NMN reliably does. In a 12-week randomized trial in healthy older men, 250 mg a day significantly increased blood NAD+ and related metabolites.[2] In a 60-day trial of 80 healthy middle-aged adults, 300, 600 and 900 mg a day all raised blood NAD+ compared with placebo, with the highest levels at 600 and 900 mg.[3] An 8-week open-label study also found that NAD+ in white blood cells increased steadily on 250 mg a day.[5] Keep in mind that a higher NAD+ blood level is a biomarker, not a health outcome.
Insulin Sensitivity And Metabolism (Evidence: Limited)
The most cited NMN study is a 10-week double-blind trial in postmenopausal women with prediabetes who were overweight or obese. Insulin-stimulated glucose uptake into muscle, measured with the gold-standard clamp method, increased with NMN but not with placebo.[1] The trial was small, and the result has not translated into broad metabolic improvements in pooled data. A 2026 meta-analysis of 15 randomized trials found no significant effects on body weight, fasting glucose, HbA1c, cholesterol or systolic blood pressure. Diastolic blood pressure fell slightly, and insulin resistance showed a non-significant downward trend.[6] In the 60-day dose trial, insulin resistance (HOMA-IR) did not differ from placebo at any dose.[3]
Physical Performance And Muscle (Evidence: Mixed)
Results here point in different directions. In the 60-day trial, six-minute walking distance increased more in all NMN groups than with placebo.[3] In older men, gait speed and left-hand grip strength improved only “nominally,” which the authors said needed confirmation in larger studies, and body composition did not change.[2] When researchers pooled trials of NMN and NR in adults with a mean age over 60, they found no meaningful benefit for grip strength, gait speed, chair-stand performance, knee strength or muscle mass.[7] If you want a supplement with stronger evidence for strength and muscle, creatine is far better studied.
Self-Rated Health And “Biological Age” (Evidence: Preliminary)
In the 60-day trial, NMN groups reported better general health scores on the SF-36 questionnaire than placebo, and a blood-based “biological age” estimate rose in the placebo group but stayed flat with NMN.[3] Biological age calculators are not validated clinical endpoints, and two months is very short for aging research, so treat these findings as hypothesis-generating.
NMN For The Brain: Is NMN A Nootropic?
NMN is often marketed for mental energy and brain aging, but the evidence is almost entirely preclinical. In a mouse model of Alzheimer’s disease, NMN reduced pathological and behavioral impairments, with supporting results in cell cultures.[11] Reviews of the field describe many positive animal studies but call for proper human trials.[10]
We found no published randomized trial testing whether NMN improves memory, attention or other cognitive outcomes in people. The closest human evidence comes from NR, the related precursor. In a 12-week randomized pilot trial of 42 older adults with amnestic mild cognitive impairment, NR doubled blood NAD+ but did not improve cognitive function, total brain blood flow or blood pressure; exploratory analyses hinted at regional blood flow changes in the hippocampus.[9] That is a useful reality check: raising NAD+ in the blood did not translate into better thinking over three months.
If cognition is your main goal, ingredients with human memory and attention trials are a better starting point. See our guides to the best supplements for memory and best supplements for focus, or ingredients such as citicoline and bacopa monnieri.
NMN Dosage: Studied Doses
Human trials have used 250 to 900 mg a day, with some meta-analyzed trials going up to 2,000 mg.[6] The most common dose is 250 mg a day, the amount in one typical capsule.
| Purpose | Dose | Duration | Study |
|---|---|---|---|
| Safety, single dose | 100, 250 or 500 mg once | Single dose | Irie 2020[4] |
| Muscle insulin sensitivity | Daily NMN vs placebo | 10 weeks | Yoshino 2021[1] |
| NAD+ and muscle function, older men | 250 mg/day | 6 or 12 weeks | Igarashi 2022[2] |
| NAD+, metabolism and sleep | 250 mg/day (2 × 125 mg) before breakfast | 8 weeks | Yamaguchi 2024[5] |
| Dose comparison, NAD+ and walking | 300, 600 or 900 mg/day | 60 days | Yi 2023[3] |
| Safety meta-analysis | 250–2,000 mg/day | 14 days to 24 weeks | Yang 2026[6] |
The dose-comparison trial found blood NAD+ and walking results peaked at 600 mg a day, with no added benefit at 900 mg.[3] That is a single trial, so 250 to 600 mg is a reasonable range that matches the published research.
Best Time To Take NMN (And NAD Precursors)
No trial has compared morning and evening dosing. Studies typically used a single daily dose, and one gave NMN before breakfast.[5] Taking it in the morning is a sensible default that mirrors the research.
Forms Of NMN And What To Look For
- Capsules and tablets: the simplest way to get a measured 250 mg dose. Some brands sell enteric-coated tablets.
- NMN powder: usually cheaper per gram and easy to scale to 500 mg or more. You need a milligram scoop or scale for accuracy.
- Sublingual NMN: marketed for faster absorption. Evidence that it produces better outcomes than swallowed NMN is lacking.
- Purity testing: choose a brand that publishes third-party certificates of analysis confirming identity and purity.
- Look for “β-NMN”: the beta form is the one named in trials such as the 60-day dose study.[3]
Is NMN Legal? The FDA’s Position On NMN
NMN’s U.S. regulatory status changed twice in three years, which is why some retailers pulled it and then brought it back.
- October 2022: in a letter to an ingredient supplier, the FDA said NMN was excluded from the definition of a dietary supplement because it had first been authorized for investigation as a new drug (a pharmaceutical version called MIB-626 shares its chemical structure). The agency elaborated on that position in a November 2022 response.[12]
- September 29, 2025: responding to a citizen petition from the Natural Products Association and the Alliance for Natural Health USA (docket FDA-2023-P-0872), the FDA reversed course. It found evidence that NMN was marketed as a dietary supplement in the U.S. as early as 2017, before the drug authorization, and concluded that “NMN is not excluded from the definition of dietary supplement.”[12]
Two caveats from the same FDA letter matter for shoppers. First, NMN is still a new dietary ingredient, so each product needs a proper premarket notification (or must source from a supplier that filed one); a product sold without it can be considered adulterated. Second, FDA acknowledgment of a notification is not an independent finding that the ingredient is safe.[12] Regulatory positions can change, so check the FDA’s website if you are reading this long after publication.
NMN Side Effects And Safety
Short-term safety data are reassuring. Single doses up to 500 mg caused no significant changes in heart rate, blood pressure, oxygen saturation or body temperature in healthy men.[4] Twelve weeks of 250 mg a day was well tolerated in older men,[2] and 60 days at up to 900 mg a day produced no safety issues based on adverse events and lab tests.[3] The 2026 meta-analysis found NMN did not increase overall, serious or system-specific adverse events and did not raise the liver enzymes ALT or AST.[6]
The important limitation is duration. The longest trials ran about 24 weeks,[6] so long-term safety over years is unknown, and NMN is often marketed for exactly that kind of indefinite use. Reviews of NMN have called for proper clinical investigation of both its effectiveness and its safety.[10]
Drug Interactions And Who Should Avoid NMN
No formal drug interaction studies on NMN have been published. As a precaution, talk with your doctor or pharmacist first if you:
- Take diabetes medication, since NMN changed insulin sensitivity in one trial[1]
- Take blood pressure medication, given the small drop in diastolic pressure in pooled data[6]
- Have, or are being treated for, cancer
- Are pregnant or breastfeeding (no safety data)
- Are under 18 (trials enrolled adults only)
How NMN Fits With Other Supplements
NMN is a longevity-focused supplement rather than a classic nootropic, so it pairs logically with other mitochondrial and “healthy aging” ingredients. None of these combinations has been tested in trials.
- Ubiquinol (CoQ10): another mitochondrial cofactor, often stacked with NAD+ precursors.
- Creatine: better evidence than NMN for muscle and strength, with emerging cognitive research.
- Curcumin phytosome: a common partner in “healthy aging” stacks.
- Cognition-focused stacks: if your goal is memory or focus, see our nootropic stacks guide and the full ingredient library.
Where To Buy NMN
Because supplement quality varies and NMN is not cheap, we point readers to Nootropics Depot, which sells NMN capsules (250 mg per capsule), enteric-coated tablets and powder and states that its products are third-party lab tested for purity and identity. We currently link to their authorized Amazon store; buy only from listings marked “Sold by Nootropics Depot.” Learn more about the company in our Nootropics Depot review.
Nootropics Depot NMN Capsules And Powder
Capsules give a fixed 250 mg dose; the powder (250 mg per serving) makes it easier to scale up toward the 500 to 600 mg range studied in one dose-comparison trial if you measure carefully.
NMN Supplement FAQs
What Does An NMN Supplement Do?
It raises NAD+ levels in the blood, which human trials have shown consistently.[2],[3] Whether that produces noticeable health benefits is still uncertain; functional results have been modest and mixed.[6],[7]
Is NMN Better Than NR?
Both raise NAD+ in people,[3],[8] and neither has strong evidence for functional benefits in older adults.[7] No large head-to-head trial shows one is superior.
How Much NMN Should I Take?
Trials used 250 to 900 mg a day. One dose-comparison trial found results peaked at 600 mg a day.[3] Many people start at 250 mg.
Does NMN Improve Memory Or Focus?
There is no human trial evidence that it does. Brain benefits come from animal studies,[11] and a trial of the related precursor NR found no cognitive improvement in people with mild cognitive impairment.[9]
Is NMN Safe To Take Every Day?
Daily use for up to about 24 weeks has looked safe in trials,[6] but data beyond that are lacking.
Is NMN Legal To Sell As A Supplement?
Yes. In September 2025, the FDA concluded NMN is not excluded from the dietary supplement definition, reversing its 2022 position. Products still need to meet new dietary ingredient notification rules.[12]
Medical disclaimer: This article is for educational purposes only and is not medical advice. Dietary supplements are not evaluated by the FDA to diagnose, treat, cure or prevent any disease. Talk with your doctor or pharmacist before starting a supplement, especially if you are pregnant, nursing, take prescription medication or have a medical condition. Read our full medical disclaimer.
References
- Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. PubMed
- Igarashi M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging. 2022;8(1):5. PubMed
- Yi L, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29-43. PubMed
- Irie J, et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J. 2020;67(2):153-160. PubMed
- Yamaguchi S, et al. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men. Endocr J. 2024;71(2):153-169. PubMed
- Yang W, et al. Safety and metabolism-related outcomes of oral nicotinamide mononucleotide supplementation in adults: a systematic review and meta-analysis. Nutrients. 2026;18(14):2251. PubMed
- Prokopidis K, et al. The effect of nicotinamide mononucleotide and riboside on skeletal muscle mass and function: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2025;16(3):e13799. PubMed
- Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults. Nat Commun. 2018;9(1):1286. PubMed
- Martens CR, et al. A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment. Alzheimers Dement. 2026;22(7):e71605. PubMed
- Nadeeshani H, et al. Nicotinamide mononucleotide (NMN) as an anti-aging health product – promises and safety concerns. J Adv Res. 2022;37:267-278. PubMed
- Ma RY, et al. Therapeutic effect of nicotinamide mononucleotide on Alzheimer’s disease through activating autophagy and anti-oxidative stress. Biomed Pharmacother. 2024;178:117199. PubMed
- U.S. Food and Drug Administration. Citizen petition response to the Natural Products Association and Alliance for Natural Health USA regarding NMN, Docket No. FDA-2023-P-0872. September 29, 2025. Regulations.gov